Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 1.000 | |
4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.864 | |
4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.696 | |
4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.687 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.661 | |
2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.615 | |
4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.615 | |
2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.606 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.605 | |
2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.604 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.591 | |
4bdi | HAU | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.590 | |
4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.579 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.573 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.573 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.573 | |
2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.564 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.558 | |
4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.529 | |
4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.527 | |
4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.526 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.519 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.516 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.516 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.516 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.516 | |
2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.512 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.511 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.510 | |
4gt3 | ATP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.509 | |
1jkl | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.507 | |
4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.507 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.506 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.505 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.505 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.502 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.501 | |
4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.498 | |
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.498 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.497 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.497 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.495 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.495 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.495 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.494 | |
4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.494 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.493 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.492 | |
3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.492 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.492 | |
4wsq | KSA | AP2-associated protein kinase 1 | 2.7.11.1 | 0.492 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.491 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.490 | |
5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.490 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.489 | |
2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.489 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.489 | |
2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.486 | |
2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.486 | |
4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.486 | |
4ft3 | H1K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.486 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.485 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.485 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.485 | |
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.485 | |
2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.484 | |
3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 0.484 | |
2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.483 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.481 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.481 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.480 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.479 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.479 | |
3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.479 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.479 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.477 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.477 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.476 | |
1pxm | CK5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
3axw | TID | Casein kinase II subunit alpha | 2.7.11.1 | 0.475 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.475 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.475 | |
5upj | UIN | Gag-Pol polyprotein | / | 0.475 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
3qai | XNN | Ketohexokinase | / | 0.474 | |
4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.473 | |
4ftq | 4HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.472 | |
4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.472 | |
2wmr | ZYR | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
4hyi | 1AO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.470 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
5av3 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.469 | |
1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.468 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.468 | |
3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.468 | |
4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.467 | |
4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.466 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.466 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.466 | |
4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.466 | |
1zys | 199 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.465 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.465 | |
3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.465 | |
3q92 | XNB | Ketohexokinase | / | 0.464 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.463 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.462 | |
3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.462 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.462 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.461 | |
3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
3t8o | ATP | Rhodopsin kinase | / | 0.461 | |
4bi1 | ZO6 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.461 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.461 | |
2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.460 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.460 | |
3eb0 | DRK | Uncharacterized protein | / | 0.460 | |
3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.460 | |
4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.460 | |
4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
4hys | 1BJ | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.460 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
3qd3 | 3Q5 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.459 | |
1ke5 | LS1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.458 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.458 | |
3llt | ANP | Protein serine/threonine kinase-1 | / | 0.458 | |
3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.458 | |
4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.458 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.457 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.457 | |
4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.457 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.457 | |
5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.457 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.457 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.456 | |
2xyn | VX6 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.456 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.456 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.456 | |
3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.456 | |
4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.456 | |
4fta | H5K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
4joa | 3DK | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.456 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
4a9s | RU9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
4fsm | HK1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.455 | |
2zmd | 537 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.454 | |
3gu8 | 3GU | Death-associated protein kinase 1 | 2.7.11.1 | 0.454 | |
3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.454 | |
3nuu | JOZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.454 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
4bgh | 3I6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.454 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.454 | |
4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.454 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.454 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.452 | |
3qcx | 3Q2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
3qru | X19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
4bda | VFB | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.452 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.452 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.452 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
2bpw | 1IN | Gag-Pol polyprotein | 3.4.23.16 | 0.451 | |
2fde | 385 | Gag-Pol polyprotein | 3.4.23.16 | 0.451 | |
3i2l | 2NC | Protease | / | 0.451 | |
3l08 | ZIG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
3qtu | X44 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
4pd6 | URI | Nucleoside permease | / | 0.451 | |
4tzk | 641 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.451 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.450 | |
2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.450 | |
2yaa | ATP | Death-associated protein kinase 2 | / | 0.450 | |
4bde | CWS | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.450 | |
4fto | 3HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.450 | |
4jik | 1KO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
2bpv | 1IN | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
2yer | TQ1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
3ekt | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.449 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.449 | |
4uya | AGS | Mitogen-activated protein kinase kinase kinase 21 | 2.7.11.25 | 0.449 | |
5av4 | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.449 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.448 | |
3c4x | ATP | Rhodopsin kinase | / | 0.448 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.448 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.448 | |
4idv | 13V | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.448 | |
4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.448 | |
1cde | GAR | Phosphoribosylglycinamide formyltransferase | / | 0.447 | |
1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
1sh9 | RIT | Gag-Pol polyprotein | 3.4.23.16 | 0.447 | |
2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.447 | |
2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.447 | |
3sw7 | 19K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.447 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
5dt0 | SKE | Aurora kinase A | 2.7.11.1 | 0.447 | |
1c2t | GAR | Phosphoribosylglycinamide formyltransferase | / | 0.446 | |
1v9a | SAH | Uncharacterized protein | / | 0.446 | |
2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
2i4v | DJR | V-1 protease | / | 0.446 | |
3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.446 | |
3ekv | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
3jw2 | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.446 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.446 | |
4eny | J19 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
4fg9 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.446 | |
4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
1fm4 | DXC | Major pollen allergen Bet v 1-L | / | 0.445 | |
1hsg | MK1 | Gag-Pol polyprotein | / | 0.445 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.445 | |
3il1 | B5D | Glutamate receptor 2 | / | 0.445 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3zxt | ACP | Death-associated protein kinase 1 | 2.7.11.1 | 0.445 | |
4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.445 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.445 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.445 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.445 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.445 | |
1d4y | TPV | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
1z5m | LI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.444 | |
3n7u | NAD | Formate dehydrogenase, chloroplastic/mitochondrial | / | 0.444 | |
3oaf | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3upj | U03 | Gag-Pol polyprotein | / | 0.444 | |
4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
4h3q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
4z9r | NAD | Omega-3 polyunsaturated fatty acid synthase subunit PfaD | / | 0.444 | |
1b6p | PI7 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.443 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.443 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.443 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.443 | |
4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.443 | |
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.443 | |
1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
1idb | 0DO | Gag-Pol polyprotein | / | 0.442 | |
1pxp | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
2bpz | 3IN | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.442 | |
3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
3orp | AGS | Serine/threonine protein kinase | / | 0.442 | |
3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
3qcy | 3Q3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
3sa8 | K83 | Protease | / | 0.442 | |
4ezl | 0SE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.442 | |
4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.442 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1npa | 3NH | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
1npw | LGZ | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
2bpy | 3IN | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.441 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.441 | |
3i6o | GR6 | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.441 | |
3q5i | ANP | Protein kinase, putative | / | 0.441 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.441 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
4fv8 | E63 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.441 | |
1c2t | NHS | Phosphoribosylglycinamide formyltransferase | / | 0.440 | |
1c70 | L75 | Protease | / | 0.440 | |
1fg6 | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
1hii | C20 | Gag-Pol polyprotein | / | 0.440 | |
1rek | B8L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.440 | |
2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
2pk5 | 075 | Protease | / | 0.440 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.440 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.440 | |
2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.440 | |
3zly | YSO | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.440 | |
4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.440 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.440 | |
4njs | G08 | Protease | / | 0.440 | |
6upj | NIU | Gag-Pol polyprotein | / | 0.440 |